Pure squamous carcinoma of the urothelial tract

This phase 2 trial tests whether the drug atezolizumab can shrink tumors in people with urothelial cancer before they have surgery. Participants receive two doses of atezolizumab, then undergo standard surgery to remove the tumor. Researchers will compare tissue and blood samples…